Source:
Recombinant corresponding to aa633-659 of HEV ORF3 with beta-galactosidase (114kD) fused at the N-terminus expressed in E. coli
Applications:
Suitable for use in ELISA and Western Blot. Reacts strongly with human HEV positive serum. Other applications not tested.
Recommended Dilutions:
Optimal dilutions to be determined by the researcher.
Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 6 months after receipt at -20°C. For maximum recovery of product, centrifuge the original vial...
Source:
Recombinant corresponding to aa633-659 of HEV ORF3 with beta-galactosidase (114kD) fused at the N-terminus expressed in E. coli
Applications:
Suitable for use in ELISA and Western Blot. Reacts strongly with human HEV positive serum. Other applications not tested.
Recommended Dilutions:
Optimal dilutions to be determined by the researcher.
Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 6 months after receipt at -20°C. For maximum recovery of product, centrifuge the original vial...
Shipping & Handling
Shipped In
Cold Packs
Safety & Storage
Storage Temperature
-20°C
Safety Statement
For laboratory research and development purposes only.
Regulatory & Compliance
Specifications
SUBCLASS
Infectious Disease
APPLICATION
E WB
*USAGE / SAFETY STATEMENT
For laboratory research and development purposes only.
PURITY
≥95% by SDS-PAGE, Bradford
PHYSICAL FORM
Supplied as a liquid in 8M urea, 20mM Tris-HCl, pH 8.0, 10mM beta-mercaptoethanol
GRADE
Highly Purified
SOURCE
Recombinant, E. coli
COMMODITY CODE
30021019
Questions & Answers (0)
Citations (0)
Shipping & Handling
Shipped In
Cold Packs
Safety & Storage
Storage Temperature
-20°C
Safety Statement
For laboratory research and development purposes only.
Regulatory & Compliance
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.